autologous GPC3/NY-ESO-1/AFP-specific CD8-positive T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011640
A preparation of autologous CD8-positive T lymphocytes that are exposed, ex vivo, to multiple specific hepatocellular carcinoma (HCC) antigens, including glypican (GPC)-3, New York esophageal squamous cell carcinoma-1 (NY-ESO-1) and alpha-fetoprotein (AFP), with potential immunostimulating and antineoplastic activities. Upon infusion of the GPC3/NY-ESO-1/AFP-specific CD8-positive T lymphocytes, the T cells specifically target and lyse cells expressing the targeted HCC neoantigens.
| Identifier | MLC-T-ONC-011640 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous specific HCC antigens CD8+ T cells; autologous HCC antigens-specific CD8+ T lymphocytes; autologous HCC antigens-specific CD8-positive T lymphocytes |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011640",
"term": "autologous GPC3/NY-ESO-1/AFP-specific CD8-positive T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous CD8-positive T lymphocytes that are exposed, ex vivo, to multiple specific hepatocellular carcinoma (HCC) antigens, including glypican (GPC)-3, New York esophageal squamous cell carcinoma-1 (NY-ESO-1) and alpha-fetoprotein (AFP), with potential immunostimulating and antineoplastic activities. Upon infusion of the GPC3/NY-ESO-1/AFP-specific CD8-positive T lymphocytes, the T cells specifically target and lyse cells expressing the targeted HCC neoantigens.",
"synonyms": [
"autologous specific HCC antigens CD8+ T cells",
"autologous HCC antigens-specific CD8+ T lymphocytes",
"autologous HCC antigens-specific CD8-positive T lymphocytes"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-gpc3-ny-eso-1-afp-specific-cd8-positive-t-lymphocytes/"
}
Record 2,975 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.